Master bone formation transcription factor: compositions and methods of use
US7160722B2 · kind B2 · utility
1Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2000 |
| Grant date | Jan 9, 2007 |
| Priority date | — |
| Expiry date | May 12, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/021
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel gene expressed selectively by osteoblast lines is provided. Expression of the gene is highly restricted to cells of osteoblast lineage, including precursor cells. Also provided is a method for promoting bone formation by providing agents that bind to the novel gene within osteoblast cells to stimulate bone formation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.